J. Witjes, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Oncology)
    Ineligible company: 
    Janssen; Ferring; AstraZeneca
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Oncology)
    Ineligible company: 
    Sanofi; MSD; BMS; Ipsen; Nucleix Ltd; Astellas
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company: 
    BMS, Tocagen, MSD, Roche
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company: 
    Spectrum, Taris, BioCanCell, Cepheid, Nucleix
Return to Management of Non Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems Webcast (2021)